Proton pump inhibitor and community pharmacies: Usage profile and factors associated with long-term use.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 34111166.
- Also identified by DOI 10.1371/journal.pone.0252785 and PMC identifier 8191994.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To characterize the usage profile and the factors associated with the prolonged use of proton pump inhibitor drugs in a community pharmacy. This is a cross-sectional, prospective and observational study involving interviews with 410 patients who acquired PPI for their own use from community pharmacies. To characterize the factors associated with the prolonged use of PPI, a multivariate logistic regression model was used. Pantoprazole (42.7%) and omeprazole (31%) were the most acquired PPIs, prescribed mainly by gastroenterologists (49.5%). They are used in the morning, especially for gastrointestinal symptoms, however, they had been consumed for more than 5 years in 30% of cases. The factors associated with prolonged use are old age (OR 1.03 CI95% 1.01-1.05), body mass index (OR 1.07 CI95% 1.01-1.12), use of non-steroidal anti-inflammatories (OR 3.18 CI95% 1.20-8.43) and selective serotonin reuptake inhibitors (OR 3.5 95% CI 1.39-8.88). PPIs are adequate in terms of indication and form of use, however, prolonged use associated with old age, being overweight and use of anti-inflammatories and antidepressants is frequent.
Medical subject headings
- Pharmacies
- Proton Pump Inhibitors
- Residence Characteristics